Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
OneSource Specialty PharmaBOM:544292 -1.35%8 Interest Coverage is 1.67 as of Jun. 2026, which is 142% above its 10-year median of 0.69. GuruFocus rates BOM:544292 with a GF Score™ of 8/100. The stock has 3 warning signs investors should review. Among 379 Biotechnology companies, OneSource Specialty Pharma ranks worse than 98.15% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. OneSource Specialty Pharma's
Operating Income
for the
three
months ended in Jun. 2026 was ₹516 Mil. OneSource Specialty Pharma's Interest Expense for the
three
months ended in Jun. 2026 was ₹-308 Mil.
OneSource Specialty Pharma's interest coverage for the quarter that ended in Jun. 2026 was 1.67.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for OneSource Specialty Pharma's Interest Coverage or its related term are showing as below:
BOM:544292'
s Interest Coverage Range Over the Past 10 Years
Min: 0.21 Med: 0.69 Max: 1.16
Current: 0.45
BOM:544292's Interest Coverage is ranked worse than 98.15% of 379
companies
in the Biotechnology industry
Industry Median: 99.7
vs BOM:544292: 0.45
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
OneSource Specialty Pharma Interest Coverage Related Terms
OneSource Specialty Pharma Interest Coverage Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
BOM:544292 vs VRTX, REGN, RVMD: Interest Coverage Comparison
For the Biotechnology subindustry, OneSource Specialty Pharma's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
OneSource Specialty Pharma Interest Coverage vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, OneSource Specialty Pharma's Interest Coverage distribution charts can be found below:
* The bar in red indicates where OneSource Specialty Pharma's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OneSource Specialty Pharma (BOM:544292) has a Interest Coverage of 1.67 as of Jun. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on OneSource Specialty Pharma and its competitors. This is 142% above median its historical median of 0.69. Over the past decade, OneSource Specialty Pharma's Interest Coverage has ranged from 0.21 to 1.16. According to the industry distribution chart, OneSource Specialty Pharma ranks #372 out of 379 companies in the Biotechnology industry, placing it in the top 98.2%.
Is OneSource Specialty Pharma's Interest Coverage too high?
OneSource Specialty Pharma's current Interest Coverage of 1.67 is 142% above median its 10-year median of 0.69. Over the past 10 years, this metric has ranged from a low of 0.21 to a high of 1.16. The Biotechnology industry median Interest Coverage is 99.70. OneSource Specialty Pharma's value of 1.67 is 98.3% below this industry median. Based on the distribution chart, OneSource Specialty Pharma ranks #372 out of 379 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, OneSource Specialty Pharma has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does OneSource Specialty Pharma's Interest Coverage compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, OneSource Specialty Pharma ranks #372 out of 379 companies for Interest Coverage. This places OneSource Specialty Pharma in the lower half of its industry. The industry median Interest Coverage is 99.70. OneSource Specialty Pharma's value of 1.67 is 98.3% below this benchmark. Historically, OneSource Specialty Pharma's own Interest Coverage has ranged from 0.21 to 1.16 over the past decade. While the company's 10-year median is 0.69 vs. the industry median of 99.70, OneSource Specialty Pharma has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Biotechnology company?
The median Interest Coverage among Biotechnology companies is 99.70, based on 379 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. OneSource Specialty Pharma's current Interest Coverage of 1.67 is 98.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on OneSource Specialty Pharma and its competitors. For the Biotechnology industry, the median Interest Coverage is 99.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. OneSource Specialty Pharma's current Interest Coverage is 1.67, which is 142% above median its own 10-year median of 0.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OneSource Specialty Pharma stock overvalued right now?
OneSource Specialty Pharma (BOM:544292) has a current Interest Coverage of 1.67. The current Interest Coverage is 1.67, which is 142% above median its 10-year median of 0.69 and 98.3% below the Biotechnology industry median of 99.70. OneSource Specialty Pharma's overall GF Score™ is 8/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For OneSource Specialty Pharma (BOM:544292), the current Interest Coverage is 1.67 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
OneSource Specialty Pharma Ltd is engaged in the research, development, manufacture and commercialization of biological drug products in different injectable formats. The company also offers end-to-end CDMO services across all phases of pre-clinical and clinical development and commercial supply of biologics. The company's reportable segments are CDMO (Contract Development and Manufacturing Organization (CDMO) : Development and manufacture of pharmaceutical products and associated services); and Unit-3 Multimodal Facility and CDMO-2.
8GF Score
Get the complete analysis for BOM:544292
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544292 has been successfully added to your 
